Washington: In a breakthrough, a key India-made meningitis vaccine can now be transported or stored for up to four days without refrigeration, which could help combat the disease in poor countries. According to researchers, the meningitis A vaccine known as MenAfriVac, created to meet the needs of Africa`s meningitis belt, can now be kept in a controlled temperature chain (CTC) at temperatures of up to 40 Degree Celsius for up to four days.Costing less than USD 0.50 per dose, the innovative vaccine that is manufactured by Serum Institute of India Ltd. (SIIL) has dramatically reduced disease burden in the first countries to introduce it, according to recently-published findings.
Moeen warned over pro-Gaza Test wristbands
ISIS opens `marriage bureau` in Syria
Farmers should get better technology: PM
Delhi shame: Class 10th student gang-raped in Uttam Nagar at gun point